US Approves World’s First Crispr Gene-Editing Drug For Sickle-Cell Disease

US Approves World’s First Crispr Gene-Editing Drug For Sickle-Cell Disease

Home Health US Approves World’s First Crispr Gene-Editing Drug For Sickle-Cell Disease Sickle cell disease (SCD) is a painful, inherited blood disorder in which the body makes flawed, sickle-shaped hemoglobin, impairing the ability of red blood cells to properly carry oxygen to the body’s tissues. US Approves World’s First Crispr Gene-Editing Drug For Sickle-Cell Disease … Read more